EFMC is funding grants for EFMC organised events with the aim to support the participation of young academic scientists. Upon application, up to 50% of the registration fee for EFMC-ISMC, EFMC-ASMC, Frontiers in Medicinal Chemistry, EFMC Short Courses or the EFMC Accredited School (Urbino) will be covered by EFMC. To apply for an EFMC grant, please fill in the application form before the deadline and upload your CV, publication list, abstract, motivation letter and support letter from the supervisor.
In addition to the EFMC grants, EFMC and the Scientific Committee of ESMEC are offering 13 (10+3) scholarships for the participation to the XXXIV edition of the school, scheduled from June 28 to July 3, 2015.
The scholarships, covering the registration fee and the full board accommodation, will be assigned to PhD students enrolled in Doctoral Schools held in one of the member countries of EFMC, excluding Italy.
EFMC Roche Studentships
One of the goals of the EFMC is to enhance interactions at the industry/academia interface and to promote improved cooperation between the pharmaceutical industry and academia. EFMC therefore proposed an opportunity to broaden the awareness to European University based chemistry students of the EFMC activities by rewarding excellence accomplished during a medicinal chemistry internship in industry.
The first EFMC-Roche studentships have been announced at the EFMC ISMC Symposium held in Berlin on September 2012 by Ulrich Stilz (EFMC President) and Torsten Hoffmann (Roche). The recipients were Nicole Trainor (Imperial College, UK) and Claudio Grünenfelder (ETH Zürich, Switzerland).
The second EFMC-Roche studentships were conferred in Lisbon on occassion of the EFMC-ISMC Symposium, held on September 7-11, 2014. Corentine Laurin (University of Glasgow, UK) and Johannes Lehmann (TU München, Germany) were the recipients.
EFMC hopes that other companies supporting medicinal chemistry internship students can recognise excellence in this way. If you are interested in more information please contact
Follow us on Twitter
Follow us on LinkedIn